Cargando…
T-lymphoid progenitor-based immunotherapies: clinical perspectives for one and all
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709039/ https://www.ncbi.nlm.nih.gov/pubmed/36180781 http://dx.doi.org/10.1038/s41423-022-00927-5 |
_version_ | 1784841058005286912 |
---|---|
author | Gaudeaux, P. Moirangthem, R. D. Paillet, J. Martin-Corredera, M. Sadek, H. Rault, P. Joshi, A. Zuber, J. Soheili, T. S. Negre, O. André, I. |
author_facet | Gaudeaux, P. Moirangthem, R. D. Paillet, J. Martin-Corredera, M. Sadek, H. Rault, P. Joshi, A. Zuber, J. Soheili, T. S. Negre, O. André, I. |
author_sort | Gaudeaux, P. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9709039 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-97090392022-12-01 T-lymphoid progenitor-based immunotherapies: clinical perspectives for one and all Gaudeaux, P. Moirangthem, R. D. Paillet, J. Martin-Corredera, M. Sadek, H. Rault, P. Joshi, A. Zuber, J. Soheili, T. S. Negre, O. André, I. Cell Mol Immunol Comment Nature Publishing Group UK 2022-09-30 2022-12 /pmc/articles/PMC9709039/ /pubmed/36180781 http://dx.doi.org/10.1038/s41423-022-00927-5 Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Comment Gaudeaux, P. Moirangthem, R. D. Paillet, J. Martin-Corredera, M. Sadek, H. Rault, P. Joshi, A. Zuber, J. Soheili, T. S. Negre, O. André, I. T-lymphoid progenitor-based immunotherapies: clinical perspectives for one and all |
title | T-lymphoid progenitor-based immunotherapies: clinical perspectives for one and all |
title_full | T-lymphoid progenitor-based immunotherapies: clinical perspectives for one and all |
title_fullStr | T-lymphoid progenitor-based immunotherapies: clinical perspectives for one and all |
title_full_unstemmed | T-lymphoid progenitor-based immunotherapies: clinical perspectives for one and all |
title_short | T-lymphoid progenitor-based immunotherapies: clinical perspectives for one and all |
title_sort | t-lymphoid progenitor-based immunotherapies: clinical perspectives for one and all |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709039/ https://www.ncbi.nlm.nih.gov/pubmed/36180781 http://dx.doi.org/10.1038/s41423-022-00927-5 |
work_keys_str_mv | AT gaudeauxp tlymphoidprogenitorbasedimmunotherapiesclinicalperspectivesforoneandall AT moirangthemrd tlymphoidprogenitorbasedimmunotherapiesclinicalperspectivesforoneandall AT pailletj tlymphoidprogenitorbasedimmunotherapiesclinicalperspectivesforoneandall AT martincorrederam tlymphoidprogenitorbasedimmunotherapiesclinicalperspectivesforoneandall AT sadekh tlymphoidprogenitorbasedimmunotherapiesclinicalperspectivesforoneandall AT raultp tlymphoidprogenitorbasedimmunotherapiesclinicalperspectivesforoneandall AT joshia tlymphoidprogenitorbasedimmunotherapiesclinicalperspectivesforoneandall AT zuberj tlymphoidprogenitorbasedimmunotherapiesclinicalperspectivesforoneandall AT soheilits tlymphoidprogenitorbasedimmunotherapiesclinicalperspectivesforoneandall AT negreo tlymphoidprogenitorbasedimmunotherapiesclinicalperspectivesforoneandall AT andrei tlymphoidprogenitorbasedimmunotherapiesclinicalperspectivesforoneandall |